KEI statement to the Working Group on Amendments to the International Health Regulations December 7, 2023 KEI agrees with others that the IHR regulations should incorporate measures to address equitable access to products. KEI reminds delegations that in 2019, the… Continue Reading
Clinicaltrials-dot-Gov-HHS-15Sep2023 From the memo: This memo provides a request that the Department of Health and Human Services (HHS), working through the National Institutes of Health (NIH), use its rulemaking authority for ClinicalTrials.Gov to include data on the costs of human… Continue Reading
In May 2023, the World Health Organization (WHO) published the global vaccine market report. Underpinning this technical report on vaccine market dynamics was a strong push by WHO’s Director-General, Tedros Adhanom Ghebreyesus, for increased transparency and equity; transparency is mentioned… Continue Reading
The National Institute of Health (NIH) recently held an all-day workshop titled, “Transforming Discoveries Into Products: Maximizing NIH’s Levers to Catalyze Technology Transfer.” KEI Director James Love participated in the July 31st workshop, speaking on the panel on “How NIH… Continue Reading
On Monday, 17 July 2023, Chile, on behalf of a group of 62 WHO member states called for a more transparent, inclusive process for civil society engagement in the WHO negotiations of a pandemic treaty at the Intergovernmental Negotiating Body… Continue Reading
On the fourteenth of June, the European parliament passed sweeping legislation on the regulation of artificial intelligence. The parliament’s position was backed with an overwhelming majority of 499 votes in favor and 28 against, with 93 abstentions. The legislation, which… Continue Reading
KEI-NTIA-AI-Accountability-RFC KEI response to NTIA request for comments on AI Accountability Policy, expressing concerns over trade agreement provisions which limit the transparency of source code and algorithms RE: Notice by the National Telecommunications and Information Administration on 04/13/2023, Document Citation:… Continue Reading
On Friday, 26 May 2023, Knowledge Ecology International (KEI) delivered the following statement on WHO negotiations on a pandemic treaty. KEI makes 3 points on the INB negotiations. First, There needs to be less secrecy of the INB negotiations on… Continue Reading
KEI-USPTO-fees18may2023 Testimony of James Love Representing Knowledge Ecology International (KEI) regarding the opportunities to use differential USPTO fees to achieve additional social objectives USPTO Patent Public Advisory Committee Public Hearing on the Proposed Patent Fee Schedule May 18, 2023 Introduction… Continue Reading